List of Oncology Medication For

Breast Cancer Medicines

The treatment of breast cancer depends on several factors, including the type and stage of the cancer, its size, location, and whether it has spread to other parts of the body. Treatment options may include: Surgery, Radiation therapy, Chemotherapy, Hormone therapy, Targeted therapy, Immunotherapy.

If Breast Cancer Medicines are not yet approved or available in your area, you may give a request, to get access price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).

Abemaciclib Tablets

abemaciclib tablets,
for oral use Initial U.S. Approval: 2017

Verzenio (abemaciclib) is a medication indicated for the treatment of women with HR-positive, HER2-negative advanced or metastatic breast cancer.

Facts about abemaciclib tablets

Disease Indications-Breast Cancer
Manufacturer-Lilly
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “abemaciclib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

Ado-Trastuzumab Emtansine for Injection

Breast Cancer Medicines

ado-trastuzumab emtansine for injection,
for intravenous use Initial U.S. Approval: {YYYY}

Kadcyla (trastuzumab emtansine) is a cancer medicine that is used to treat advanced or metastatic HER2-positive breast cancer (cancer that has spread to other parts of the body) in adults who previously received trastuzumab and a taxane.

Facts about ado-trastuzumab emtansine for injection

Disease Indications-Breast Cancer
Manufacturer-Genentech, Inc
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “ado-trastuzumab emtansine for injection” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Alpelisib Tablets

Breast Cancer Medicines

alpelisib tablets, for oral use Initial U.S. Approval: 2019

As specified in the prescribing information, alpelisib tablets is indicated for the treatment of Breast Cancer. Piqray (alpelisib) is a medication used in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CAmutated, advanced or metastatic breast cancer as detected by an FDA-approved test following progression on or after an endocrine-based regimen.

Facts about alpelisib tablets

DISEASE INDICATIONS-Breast Cancer
MANUFACTURER-Novartis
USAGE-Oral
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “alpelisib tablets” based on the information you provide.

atezolizumab injection

Gastrointestinal, Breast Cancer Medicines, Lung Cancer Medicines

atezolizumab injection
for intravenous use Initial U.S. Approval: 2016

Tecentriq (atezolizumab) is a medication used for the treatment of locally advanced or metastatic urothelial carcinoma, for the treatment of metastatic non-small cell lung cancer (NSCLC), and for the treatment of advanced triple negative breast cancer (TNBC).

Facts about atezolizumab injection

DISEASE INDICATIONS-Urothelial Carcinoma, Breast Cancer, Lung Cancer
MANUFACTURER-Roche Registration Limited
USAGE-Intravenous
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Pharmaceuticals and Medical Devices Agency (PMDA), Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “atezolizumab injection” based on the information you provide.

Capecitabine tablets

Colon, Bile Duct Cancer Medicines, Breast Cancer Medicines, Esophageal, Pancreatic, Stomach

Capecitabine tablets
for oral use Initial U.S. Approval: 1998

capecitabine is a nucleoside metabolic inhibitor with antineoplastic activity indicated for: • Adjuv ant Colon Cancer –Patients with Dukes’ C colon cancer • Metastatic Colorectal Cancer –First-line as monotherapy when treatment with fluoropyrimidine therapy alone is preferred • Metastatic Breast Cancer –In combination with docetaxel after failure of prior anthracyclinecontaining therapy –As monotherapy in patients resistant to both paclitaxel and an anthracycline-containing regimen

Facts about capecitabine tablets

Approval Date: 1998
Proprietary Name: On Request
Active Ingredient(s): capecitabine tablets
Dosage Forms And Strengths: Tablets: 150 mg and 500 mgTablets: 150 mg and 500 mg
Company: Genentech
Current indications: Breast cancer, Colorectal cancer, Pancreatic adenocarcinoma, Stomach (gastric) cancer, esophageal cancer, or gastroesophageal junction cancer in adults, Stomach (gastric) cancer or gastroesophageal junction cancer in adults.
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import capecitabine tablets” based on the information you provide.

Capivasertib Tablets, for oral use Initial U.S. Approval: 2023

Breast Cancer Medicines

Capivasertib Tablets, for oral use Initial U.S. Approval: 2023

Truqap is used to treat breast cancers that are:

metastatic and have grown after treatment with at least one hormonal therapy medicine.
locally advanced and have grown within the year after adjuvant treatment was complete; adjuvant treatments are treatments given after breast cancer surgery.

Approval Date: 2023
Proprietary Name: TRUQAP
Active Ingredient(s): capivasertib
FDA-approved use: To treat patients with HER2-negative breast cancer
Dosage Form: Tablets
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Capivasertib Tablets” based on the information you provide.

Docetaxel Injection

Prostate, Breast Cancer Medicines, Gastrointestinal, Head And Neck, Lung Cancer Medicines

docetaxel Injection
for intravenous use Initial U.S. Approval: 1996

docetaxel Injection is a prescription anticancer medicine used to treat certain people with: • breast cancer • non-small cell lung cancer • prostate cancer • stomach cancer • head and neck cancer It is not known if TAXOTERE is effective in children. What are the ingredients in TAXOTERE? Active ingredient: docetaxel Inactive ingredients: polysorbate 80 and dehydrated alcohol solution.

Facts about docetaxel Injection

Approval Date: 1996
Proprietary Name: On Request
Active Ingredient(s): docetaxel Injection
Dosage Forms And Strengths: Injection: One-vial TAXOTERE: Single-dose vials 20 mg/mL and 80 mg/4 mL
Company: sanofi aventis
Current indications:
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import docetaxel Injection” based on the information you provide.

Eflapegrastim-xnst Injection

Breast Cancer Medicines, Lung Cancer Medicines

eflapegrastim-xnst injection
for subcutaneous use Initial U.S. Approval: 2022

Rolvedon (eflapegrastim-xnst) is a leukocyte growth factor used to decrease the incidence of infection, as manifested by febrile neutropenia, in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with clinically significant incidence of febrile neutropenia. FDA-approved use: To decrease the incidence of infection in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with clinically significant incidence of febrile neutropenia

Facts about eflapegrastim-xnst injection

Approval Date: 9/9/2022
Proprietary Name: Rolvedon
Active Ingredient(s): eflapegrastim-xnst
Dosage Form: Injection
DISEASE INDICATIONS-Breast Cancer, Lung Cancer
MANUFACTURER-Spectrum Pharmaceuticals, Inc.
USAGE-Intravenous
MEDICINE APPROVED BY-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “eflapegrastim-xnst injection” based on the information you provide.

Elacestrant Tablets

Breast Cancer Medicines

Brand Name: ORSERDU Generic Name: elacestrant
ORSERDU(elacestrant) is used to treat breast cancer disease.

As specified in the prescribing information, Orserdu (elacestrant) is indicated for the treatment of breast cancer disease. As per highlights Of prescribing information (elacestrant) tablets is an estrogen receptor antagonist indicated for: • treatment of postmenopausal women or adult men, with ERpositive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.

Brand Name:	ORSERDU – On Request
Generic Name:	elacestrant tablets
Strength:	Tablets: 345 mg and 86 mg
Manufacturer:	Stemline Therapeutics
Approved By:	USFDA

Source Details: Patient Information

Extra Information:

Full prescribing information [FDA]: Orserdu (elacestrant) [PDF] Stemline Therapeutics, Inc., January 2023.
FDA approves elacestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer FDA, January 2023

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “elacestrant tablets” based on the information you provide.

Everolimus Tablets

Breast Cancer Medicines, Gastrointestinal, Kidney, Lung Cancer Medicines

everolimus tablets for oral suspension
Initial U.S. Approval: 2009

Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis.

Facts about everolimus tablets

Disease Indications-Breast Cancer, Gastric Cancer, Kidney Cancer, Lung Cancer, Intestinal Cancer
Manufacturer-Novartis
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Therapeutic Goods Administration (TGA).
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “everolimus tablets” based on the information you provide.

« Older Entries

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Breast Cancer Medicines

abemaciclib tablets, for oral use Initial U.S. Approval: 2017

Facts about abemaciclib tablets

Access the best support services globally

ado-trastuzumab emtansine for injection, for intravenous use Initial U.S. Approval: {YYYY}

Facts about ado-trastuzumab emtansine for injection

Access the best support services globally

alpelisib tablets, for oral use Initial U.S. Approval: 2019

Access the best support services globally

atezolizumab injection for intravenous use Initial U.S. Approval: 2016

Facts about atezolizumab injection

Access the best support services globally

Capecitabine tablets for oral use Initial U.S. Approval: 1998

Facts about capecitabine tablets

Access the best support services globally

Capivasertib Tablets, for oral use Initial U.S. Approval: 2023

Access the best support services globally

docetaxel Injection for intravenous use Initial U.S. Approval: 1996

Facts about docetaxel Injection

Access the best support services globally

eflapegrastim-xnst injection for subcutaneous use Initial U.S. Approval: 2022

Facts about eflapegrastim-xnst injection

Access the best support services globally

Brand Name: ORSERDU Generic Name: elacestrant ORSERDU(elacestrant) is used to treat breast cancer disease.

Extra Information:

Access the best support services globally

everolimus tablets for oral suspension Initial U.S. Approval: 2009

Facts about everolimus tablets

Access the best support services globally

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

abemaciclib tablets,
for oral use Initial U.S. Approval: 2017

ado-trastuzumab emtansine for injection,
for intravenous use Initial U.S. Approval: {YYYY}

atezolizumab injection
for intravenous use Initial U.S. Approval: 2016

Capecitabine tablets
for oral use Initial U.S. Approval: 1998

docetaxel Injection
for intravenous use Initial U.S. Approval: 1996

eflapegrastim-xnst injection
for subcutaneous use Initial U.S. Approval: 2022

Brand Name: ORSERDU Generic Name: elacestrant
ORSERDU(elacestrant) is used to treat breast cancer disease.

everolimus tablets for oral suspension
Initial U.S. Approval: 2009